Navigation Links
Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
Date:11/20/2007

EMERYVILLE, Calif., Nov. 20 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. ("NTI") (Nasdaq: NTII) today announced that it was notified on November 19, 2007 by The NASDAQ Stock Market that it has regained compliance with applicable NASDAQ Capital Market continued listing standards. Previously, the NASDAQ Listing Qualifications Department had notified NTI that it was not in compliance with the $35 million market value of listed securities continued listing requirement. NTI regained compliance following the closing on November 2, 2007 of its underwritten stock offering, in which it raised gross proceeds of $60 million and net proceeds of approximately $55 million through the offering and sale of 21,818,181 shares of common stock.

About Neurobiological Technologies, Inc.

NTI is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stage clinical trials for central nervous system conditions. The company is currently developing Viprinex(TM) (ancrod), a novel reperfusion agent that is in pivotal Phase 3 trials for the treatment of acute ischemic stroke.


'/>"/>
SOURCE Neurobiological Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Neurobiological Technologies Reports Going Concern Qualification
2. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
3. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
4. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
5. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
6. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
7. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
8. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
9. Advanced technologies aim to transform the coaching of top athletes
10. Global Med Technologies(R) Extends Its Worldwide Outreach
11. Acuo Technologies(R) Names Mike Dolan Vice President of Sales

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...WHAT: ,, TheBerylInstitute, theresearchandedu...ghealthcareexclusivecallcenter,issponsoringafreeWe...tionwithapositivecustomerserviceexperience.Hostedb...llsupplementHowe,sJune2009whitepaper,"CustomerExpe...consumerswillultimatelytransformhealthcaredelivery...
(Date:11/23/2009)...-InasurveyofNewJerseyandPhiladelphiaregionalChiefE...tdonotbelieveanewhealthcarebillwouldlikelyresultin...fthelatestsurveyconductedbytheAlloySilversteinGrou...listat85percentasthebiggestnationalissue.Thissurve...niesfromallpartsofNewJerseyandSoutheasternPennsylv...
(Date:11/23/2009)...self-reported by American surgeons are strongly re...gs appear today in the online edition of Annals o...laborators from Johns Hopkins and the American Col..., nearly 9 percent of U.S. surgeons responding sai...r to being surveyed. Over 70 percent attributed th...
(Date:11/23/2009)...r more screen time than those in center-based care...hDay News) --Young children of working parents may...s reports have found, especially kids in home-base...rchers from Seattle Children,s Hospital and the Un... to find out how much television viewing was avail...
(Date:11/23/2009)...UnitedConcordiaDental,oneofthenation,slargestdenta...ww.unitedconcordia.comwhichprovidesimprovedaccesst...sts. ,, "Thesiteboastsacleandesign,betterorgani...visitorsfindinformationquicklyandeasily,"saidPaulJ...tor."Fresh,relevantcontent,coupledwithanimprovedea...
Breaking Medicine News(10 mins):Health News:Tips to Improve Healthcare Customer Service Across All Generations 2Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:Day Care Boosts Kids' TV Time 2Health News:Day Care Boosts Kids' TV Time 3
...v. 19 Care Improvement Plus today announced that ...del Partner Award" from the Atlanta Metropolitan P...mprovement Plus for developing a series of health ... University of Georgia Cooperative Extension Serv...
...K, Nov. 19 DECEMBER 2008 articles include: , ...Twilight star Cam Gigandet has a number of goals ...eat career and general happiness. He shares his i...s O.C. co-stars, Gigandet is candid about how he p...
...approach could aid research, treatment, experts sa...-- U.S. researchers say they,ve developed a new lo...ival of cancer-killing cells within the body. , Mo...tanford University School of Medicine reports. How...
..., Nov. 19 Today talk show host, Larry King,turns ...King Cardiac,Foundation, COPE Health Solutions and...e second annual King of Hearts gala in Los Angeles...ed a heart,attack, one that led to quintuple-bypas...
... Va., Nov. 19 Recognizing November 20th as the 33...an Cancer Society, the National Community Pharmaci...resolution asking its pharmacist members to consid...od health and the use of tobacco products is an un...
... Nov. 19 In nearly one third of all people who,su...jury is not readily,evident to doctors. Atrial fi...ieved to be a significant factor in many of these ...y.org/cgi/content/abstract/71/21/1696 ) that a new...
Other Medicine News:Health News:Care Improvement Plus Recognized with Metropolitan Partnership in Aging Award 2Health News:Highlights from the December 2008 Issue of Men's Health: On Newsstands November 18th, 2008 2Health News:Highlights from the December 2008 Issue of Men's Health: On Newsstands November 18th, 2008 3Health News:Highlights from the December 2008 Issue of Men's Health: On Newsstands November 18th, 2008 4Health News:Technique Tracks Cancer-Killing Cells 2Health News:The King of Hearts Helps Others Follow a Healthy Road 2Health News:The King of Hearts Helps Others Follow a Healthy Road 3Health News:The King of Hearts Helps Others Follow a Healthy Road 4Health News:NCPA Encourages Member Pharmacists to Consider Refraining From Selling Tobacco Products 2Health News:Study Suggests Need for More Aggressive Outpatient Monitoring of Patients' Hearts When Cause of Stroke is Unclear 2Health News:Study Suggests Need for More Aggressive Outpatient Monitoring of Patients' Hearts When Cause of Stroke is Unclear 3
(Date:11/23/2009)...,Nov.23/PRNewswire/--LightSciencesOncology,Inc.(LS...oftheBoard,Elekta,toanewlycreatedseatonitsboardofd...medical-productcompanies,includingElekta,tomarketl...gsadditionalstrengthinbusinessdevelopmenttotheboar...ighisaworldleaderincancer-therapybusinessdevelopme...
(Date:11/23/2009)....,Nov.23/PRNewswire-FirstCall/-- CumberlandPharmac...p-lineresultsfromastudyevaluatingthesafetyandeffic...inhospitalizedburnpatients. ,, Statisticalsigni...everinburnpatientsoverthefirst24hoursoftreatment.T...rddegreeburnscoveringmorethan10percenttotalbodysur...
(Date:11/23/2009)...s,Nov.23/PRNewswire-FirstCall/--WoundManagementTec...ingproviderofspecialtymedicalproducts,announcedtha...comprehensivemanagementbusinessupdatetoillustratet...2009salesincreased33.5%to$102,926vs.Q32008salesof$...asedto$3,327,892vs.Q32008shareholderequityof$(321,...
Breaking Medicine Technology:Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Futronic Windows 7 Biometric Framework Driver is Signed by Microsoft 10364 1Futronic Windows 7 Biometric Framework Driver is Signed by Microsoft 10364 2WarrantyElephant Launches 26quot 3BMediElephant 26quot 3B a New Medication Reminder Service Inspired by WarrantyElephant User Rhonda Lewis Founder o 59503 1WarrantyElephant Launches 26quot 3BMediElephant 26quot 3B a New Medication Reminder Service Inspired by WarrantyElephant User Rhonda Lewis Founder o 59503 2You Me and Tea is Pleased to Announce the Website Debut of youmeandtea com 59498 1You Me and Tea is Pleased to Announce the Website Debut of youmeandtea com 59498 2
..., Calif., June 2 ,Bayer HealthCare Pharmaceuticals...XX ) today announced the presentation of new clini...elopment program for Nexavar(R),(sorafenib) tablet...gastric and ovarian cancers. Nexavar is currently ...nt of patients with unresectable liver cancer and,...
...edarex, Inc.,(Nasdaq: MEDX ) today announced prel...1106 (ONO-4538: development code of Ono Pharmaceut...Data presented from patients with,recurrent or tre... safety,tolerability and pharmacokinetic profile o...vidence of anti-tumor activity was observed,includ...
Other Medicine Technology:New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 2New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 3New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 4New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 5New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 6Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 2Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 3Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 4
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: